SEC Form 4 · accession 0000919574-17-005170
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neal C Bradsher
Director · 10% Owner
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTION TO PURCHASE COMMON SHARESF5,F1,F3 | $3.15 | Jul 1, 2017 | A | 20,000 | A | — | Jun 30, 2022 | COMMON SHARES | 20,000 | 20,000 | D |
| OPTION TO PURCHASE COMMON SHARESF1,F4 | $2.72 | holding | — | — | — | — | Jun 30, 2021 | COMMON SHARES | 20,000 | 20,000 | D |
| OPTION TO PURCHASE COMMON SHARESF1,F4 | $3.57 | holding | — | — | — | — | Jun 30, 2020 | COMMON SHARES | 20,000 | 20,000 | D |
| OPTION TO PURCHASE COMMON SHARESF1,F4 | $3.11 | holding | — | — | — | — | Jun 30, 2019 | COMMON SHARES | 20,000 | 20,000 | D |
| OPTION TO PURCHASE COMMON SHARESF1,F4 | $4.13 | holding | — | — | — | — | Jun 30, 2018 | COMMON SHARES | 20,000 | 20,000 | D |
| OPTION TO PURCHASE COMMON SHARESF2,F4 | $5.00 | holding | — | — | — | — | Jun 4, 2018 | COMMON SHARES | 50,000 | 50,000 | I |
Explanation of responses
- F1These securities are directly owned by Neal C. Bradsher.
- F2The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc., as General Partner of Broadwood Partners, L.P., and Neal C. Bradsher, as President of Broadwood Capital, Inc. Each of Broadwood Capital, Inc. and Neal C. Bradsher disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that Broadwood Capital, Inc. or Neal C. Bradsher is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F3These options will vest and become exercisable in four quarterly installments on September 30, 2017, December 31, 2017, March 31, 2018, and June 30, 2018, provided that Neal C. Bradsher remains a director on the last day of each quarter.
- F4These options are currently exercisable.
- F5The options were granted to Neal Bradsher by the issuer on July 1, 2017 as director compensation pursuant to the issuer's 2012 Equity Incentive Plan.